BCMIO
AZN icon

Beacon Capital Management Inc (Ohio)’s AstraZeneca AZN Stock Holding History

Beacon Capital Management Inc (Ohio)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2
Closed – – 77
2017
Q1 		$0 Buy
+2
New +$116 ﹤0.01% 81
2015
Q2 		– Sell
-218
Closed -$15K – 239
2015
Q1 		$15K Buy
+218
New +$15.1K ﹤0.01% 120

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Beacon Capital Management Inc (Ohio)'s AZN Position: Q2 2017 in Review

Beacon Capital Management Inc (Ohio) sold out of AstraZeneca (AZN) in Q2 2017, closing a stake of 2 shares.

Beacon Capital Management Inc (Ohio) first reported a position in AZN in Q1 2015 and held it in 2 quarters. The position peaked at $15K in Q1 2015. 466 funds tracked by Wall St. Rank hold AZN as of Q2 2017.

  • Beacon Capital Management Inc (Ohio) reported no remaining AstraZeneca position as of Q2 2017 after selling out during the quarter.
  • Beacon Capital Management Inc (Ohio) sold 2 AstraZeneca shares in Q2 2017.
  • Beacon Capital Management Inc (Ohio) first reported a position in AstraZeneca in Q1 2015 and held it in 2 quarters.
  • Beacon Capital Management Inc (Ohio)'s AstraZeneca position peaked at $15K in Q1 2015.
  • 466 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2017.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q2 2017, filed 11 Jul 2017.